Skip to main content
Medical information Clinical review pending

Genetic Testing

PPP1R8 Gene Cardiac Defects PPP1R8 Related Genetic Test

Genetic test using Next Generation Sequencing (NGS) to identify mutations in the PPP1R8 gene associated with cardiac defects. Helps understand genetic risk for cardiovascular conditions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (typically collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
Results
Results are typically available within 3 to 4 weeks. Confirm exact turnaround time with the laboratory before booking.
Preparation
No special preparation is typically required for this blood test. However, confirm with the laboratory for any specific instructions.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the PPP1R8 Gene Cardiac Defects PPP1R8 Related Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of cardiac defects or cardiovascular disease
  • ✓Unexplained heart murmurs or arrhythmias
  • ✓Individuals considering cardiac surgery
  • ✓Genetic counseling for heart conditions
  • ✓Understanding genetic risk for cardiovascular issues
02

In plain language

What this test helps you understand

Identifies mutations in the PPP1R8 gene associated with cardiac defects. Provides insights into genetic predisposition to cardiovascular disorders. Can inform personalized treatment and management strategies.
This test examines the PPP1R8 gene to identify genetic mutations linked to cardiac defects. Using Next Generation Sequencing (NGS) technology, it helps understand the genetic basis of certain cardiovascular disorders. This information can assist healthcare providers in developing personalized management strategies. The test analyzes your genetic material to detect specific mutations in the PPP1R8 gene that may increase the risk of developing heart conditions. Early identification of these genetic predispositions can lead to proactive health management and informed decisions about treatment and lifestyle changes. Understanding familial risk factors through this test also allows for targeted screening of family members.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is typically required for this blood test. However, confirm with the laboratory for any specific instructions.
SampleBlood sample (typically collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
MethodologyNext Generation Sequencing (NGS) is used to analyze the PPP1R8 gene for specific mutations.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test specifically analyzes the PPP1R8 gene. It does not detect mutations in other genes that may cause cardiac defects. A negative result does not completely rule out a genetic cause for heart conditions. The test may not detect all possible mutations within the PPP1R8 gene.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The PPP1R8 gene provides instructions for making a protein involved in heart muscle function. Mutations in this gene are associated with certain types of heart defects.
Individuals with a family history of heart problems, unexplained heart symptoms, or those seeking genetic counseling before heart surgery may benefit from this test.
Results should be discussed with a healthcare professional, such as a genetic counselor or cardiologist, who can explain the findings in the context of your personal and family medical history.
A positive result indicates the presence of a mutation in the PPP1R8 gene associated with cardiac defects. Your doctor can discuss the implications for your health and potential management strategies.
Insurance coverage varies. Confirm coverage details with your insurance provider before proceeding with the test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp